• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

变构肽激活物促进原肝生长因子刺激 Met 信号。

Allosteric peptide activators of pro-hepatocyte growth factor stimulate Met signaling.

机构信息

Department of Protein Engineering, Genentech, Inc, South San Francisco, California 94080, USA.

出版信息

J Biol Chem. 2010 Dec 17;285(51):40362-72. doi: 10.1074/jbc.M110.179721. Epub 2010 Oct 11.

DOI:10.1074/jbc.M110.179721
PMID:20937841
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3001016/
Abstract

Hepatocyte growth factor (HGF) binds to its target receptor tyrosine kinase, Met, as a single-chain form (pro-HGF) or as a cleaved two-chain disulfide-linked α/β-heterodimer. However, only two-chain HGF stimulates Met signaling. Proteolytic cleavage of the Arg(494)-Val(495) peptide bond in the zymogen-like pro-HGF results in allosteric activation of the serine protease-like β-chain (HGF β), which binds Met to initiate signaling. We use insights from the canonical trypsin-like serine protease activation mechanism to show that isolated peptides corresponding to the first 7-10 residues of the cleaved N terminus of the β-chain stimulate Met phosphorylation by pro-HGF to levels that are ∼25% of those stimulated by two-chain HGF. Biolayer interferometry data demonstrate that peptide VVNGIPTR (peptide V8) allosterically enhances pro-HGF β binding to Met, resulting in a K(D)(app) of 1.6 μm, only 8-fold weaker than the Met/HGF β-chain affinity. Most notably, in vitro cell stimulation with peptide V8 in the presence of pro-HGF leads to Akt phosphorylation, enhances cell survival, and facilitates cell migration between 75 and 100% of that found with two-chain HGF, thus revealing a novel approach for activation of Met signaling that bypasses proteolytic processing of pro-HGF. Peptide V8 is unable to enhance Met binding or signaling with HGF proteins having a mutated activation pocket (D672N). Furthermore, Gly substitution of the N-terminal Val residue in peptide V8 results in loss of all activity. Overall, these findings identify the activation pocket of the serine protease-like β-chain as a "hot spot" for allosteric regulation of pro-HGF and have broad implications for developing selective allosteric activators of serine proteases and pseudoproteases.

摘要

肝细胞生长因子 (HGF) 以单链形式(原 HGF)或切割的二硫键连接的α/β-异源二聚体形式结合其靶受体酪氨酸激酶 Met。然而,只有二聚体 HGF 刺激 Met 信号转导。原 HGF 中的精氨酸 (494)-缬氨酸 (495) 肽键的蛋白水解切割导致酶原样β-链(HGF β)的别构激活,该β-链与 Met 结合以启动信号转导。我们利用经典的胰蛋白酶样丝氨酸蛋白酶激活机制的见解表明,与β-链切割 N 端的前 7-10 个残基相对应的分离肽刺激原 HGF 诱导 Met 磷酸化的水平达到二聚体 HGF 刺激水平的约 25%。生物层干涉数据表明,肽 VVNGIPTR(肽 V8)别构增强了原 HGF β 与 Met 的结合,导致 K(D)(app)为 1.6 μm,仅比 Met/HGF β-链亲和力弱 8 倍。值得注意的是,在存在原 HGF 的情况下,用肽 V8 体外刺激细胞导致 Akt 磷酸化,增强细胞存活,并促进细胞迁移,与二聚体 HGF 相比提高了 75%至 100%,从而揭示了一种绕过原 HGF 蛋白水解加工的 Met 信号转导激活的新方法。肽 V8 不能增强具有突变激活口袋(D672N)的 HGF 蛋白与 Met 的结合或信号转导。此外,肽 V8 中 N 端 Val 残基的 Gly 取代导致失去所有活性。总体而言,这些发现确定了丝氨酸蛋白酶样β-链的激活口袋是原 HGF 别构调节的“热点”,并对开发丝氨酸蛋白酶和假丝氨酸蛋白酶的选择性别构激活剂具有广泛的意义。

相似文献

1
Allosteric peptide activators of pro-hepatocyte growth factor stimulate Met signaling.变构肽激活物促进原肝生长因子刺激 Met 信号。
J Biol Chem. 2010 Dec 17;285(51):40362-72. doi: 10.1074/jbc.M110.179721. Epub 2010 Oct 11.
2
An allosteric switch for pro-HGF/Met signaling using zymogen activator peptides.使用酶原激活肽的原 HGF/Met 信号的别构开关。
Nat Chem Biol. 2014 Jul;10(7):567-73. doi: 10.1038/nchembio.1533. Epub 2014 May 25.
3
Structural and functional basis of the serine protease-like hepatocyte growth factor beta-chain in Met binding and signaling.肝细胞生长因子β链中丝氨酸蛋白酶样结构域在Met结合和信号传导中的结构与功能基础。
J Biol Chem. 2004 Sep 17;279(38):39915-24. doi: 10.1074/jbc.M404795200. Epub 2004 Jun 24.
4
Utilizing the activation mechanism of serine proteases to engineer hepatocyte growth factor into a Met antagonist.利用丝氨酸蛋白酶的激活机制将肝细胞生长因子改造为一种Met拮抗剂。
Proc Natl Acad Sci U S A. 2007 Mar 27;104(13):5306-11. doi: 10.1073/pnas.0700184104. Epub 2007 Mar 19.
5
Unusual proteolytic activation of pro-hepatocyte growth factor by plasma kallikrein and coagulation factor XIa.血浆激肽释放酶和凝血因子XIa对肝细胞生长因子前体的异常蛋白水解激活作用。
J Biol Chem. 2002 Dec 6;277(49):47804-9. doi: 10.1074/jbc.M209778200. Epub 2002 Oct 7.
6
Noncompetitive inhibition of hepatocyte growth factor-dependent Met signaling by a phage-derived peptide.噬菌体衍生肽对肝细胞生长因子依赖性Met信号传导的非竞争性抑制作用
J Mol Biol. 2009 Jan 9;385(1):79-90. doi: 10.1016/j.jmb.2008.09.091. Epub 2008 Oct 15.
7
Identification of functional domains in the hepatocyte growth factor and its receptor by molecular engineering.通过分子工程鉴定肝细胞生长因子及其受体中的功能结构域。
J Biotechnol. 1994 Sep 30;37(2):109-22. doi: 10.1016/0168-1656(94)90002-7.
8
Pseudo-active sites of protease domains: HGF/Met and Sonic hedgehog signaling in cancer.蛋白酶结构域的伪活性位点:HGF/Met 和 Sonic hedgehog 信号通路与癌症。
Biol Chem. 2010 Aug;391(8):881-92. doi: 10.1515/BC.2010.098.
9
Cooperative interaction between alpha- and beta-chains of hepatocyte growth factor on c-Met receptor confers ligand-induced receptor tyrosine phosphorylation and multiple biological responses.肝细胞生长因子的α链和β链在c-Met受体上的协同相互作用赋予配体诱导的受体酪氨酸磷酸化及多种生物学反应。
J Biol Chem. 1998 Sep 4;273(36):22913-20. doi: 10.1074/jbc.273.36.22913.
10
Matriptase is required for the active form of hepatocyte growth factor induced Met, focal adhesion kinase and protein kinase B activation on neural stem/progenitor cell motility.肝细胞生长因子的活性形式诱导的Met、粘着斑激酶和蛋白激酶B的激活对神经干/祖细胞迁移是必需的,而Matriptase参与其中。
Biochim Biophys Acta. 2014 Jul;1843(7):1285-94. doi: 10.1016/j.bbamcr.2014.03.020. Epub 2014 Mar 28.

引用本文的文献

1
Genetic investigations on singleton school aged children reveal novel variants and new candidate genes for hearing loss.对单胎学龄儿童的遗传研究揭示了听力损失的新变异和新候选基因。
Sci Rep. 2024 Sep 13;14(1):21412. doi: 10.1038/s41598-024-71407-1.
2
Engineering, Characterization, and Biological Evaluation of an Antibody Targeting the HGF Receptor.工程、表征和针对 HGF 受体的抗体的生物学评估。
Front Immunol. 2021 Dec 3;12:775151. doi: 10.3389/fimmu.2021.775151. eCollection 2021.
3
Dimer Interface in Natural Variant NK1 Is Dispensable for HGF-Dependent Met Receptor Activation.天然变异型 NK1 中的二聚体界面对于 HGF 依赖性 Met 受体激活是可有可无的。
Int J Mol Sci. 2021 Aug 26;22(17):9240. doi: 10.3390/ijms22179240.
4
Hepsin enhances liver metabolism and inhibits adipocyte browning in mice.Hepsin 增强了小鼠的肝脏代谢,并抑制了脂肪细胞的棕色化。
Proc Natl Acad Sci U S A. 2020 Jun 2;117(22):12359-12367. doi: 10.1073/pnas.1918445117. Epub 2020 May 13.
5
Residues W215, E217 and E192 control the allosteric E*-E equilibrium of thrombin.残基 W215、E217 和 E192 控制凝血酶的变构 E*-E 平衡。
Sci Rep. 2019 Aug 23;9(1):12304. doi: 10.1038/s41598-019-48839-1.
6
Probing conformational and functional states of human hepatocyte growth factor by a panel of monoclonal antibodies.用一组单克隆抗体探测人肝细胞生长因子的构象和功能状态。
Sci Rep. 2016 Sep 9;6:33149. doi: 10.1038/srep33149.
7
Design of Specific Serine Protease Inhibitors Based on a Versatile Peptide Scaffold: Conversion of a Urokinase Inhibitor to a Plasma Kallikrein Inhibitor.基于通用肽支架的特异性丝氨酸蛋白酶抑制剂的设计:将尿激酶抑制剂转化为血浆激肽释放酶抑制剂。
J Med Chem. 2015 Nov 25;58(22):8868-76. doi: 10.1021/acs.jmedchem.5b01128. Epub 2015 Nov 12.
8
An engineered dimeric fragment of hepatocyte growth factor is a potent c-MET agonist.一种工程化的肝细胞生长因子二聚体片段是一种有效的c-MET激动剂。
FEBS Lett. 2014 Dec 20;588(24):4831-7. doi: 10.1016/j.febslet.2014.11.018. Epub 2014 Nov 21.
9
Allosteric targeting of receptor tyrosine kinases.变构靶向受体酪氨酸激酶。
Nat Biotechnol. 2014 Nov;32(11):1113-20. doi: 10.1038/nbt.3028.
10
A novel synthetic small molecule YH-306 suppresses colorectal tumour growth and metastasis via FAK pathway.一种新型合成小分子YH-306通过FAK途径抑制结直肠癌的生长和转移。
J Cell Mol Med. 2015 Feb;19(2):383-95. doi: 10.1111/jcmm.12450. Epub 2014 Oct 29.

本文引用的文献

1
Structural basis for agonism and antagonism of hepatocyte growth factor.肝细胞生长因子激动剂和拮抗剂作用的结构基础。
Proc Natl Acad Sci U S A. 2010 Jul 27;107(30):13264-9. doi: 10.1073/pnas.1005183107. Epub 2010 Jul 12.
2
The discovery of hepatocyte growth factor (HGF) and its significance for cell biology, life sciences and clinical medicine.肝细胞生长因子(HGF)的发现及其在细胞生物学、生命科学和临床医学中的意义。
Proc Jpn Acad Ser B Phys Biol Sci. 2010;86(6):588-610. doi: 10.2183/pjab.86.588.
3
Hepatocyte growth factor activator (HGFA): pathophysiological functions in vivo.肝细胞生长因子激活剂 (HGFA):体内的病理生理功能。
FEBS J. 2010 May;277(10):2230-7. doi: 10.1111/j.1742-4658.2010.07640.x. Epub 2010 Apr 9.
4
Turning enzymes ON with small molecules.利用小分子激活酶。
Nat Chem Biol. 2010 Mar;6(3):179-188. doi: 10.1038/nchembio.318.
5
Hepatocyte growth factor activation inhibitors - therapeutic potential in cancer.肝细胞生长因子激活抑制剂 - 癌症治疗潜力。
Anticancer Agents Med Chem. 2010 Jan;10(1):47-57. doi: 10.2174/1871520611009010047.
6
Small-molecule activators of a proenzyme.一种酶原的小分子激活剂。
Science. 2009 Nov 6;326(5954):853-8. doi: 10.1126/science.1177585.
7
Nonproteolytic induction of catalytic activity into the single-chain form of urokinase-type plasminogen activator by dipeptides.二肽对单链尿激酶型纤溶酶原激活剂催化活性的非蛋白水解诱导作用
Biochemistry. 2009 Oct 13;48(40):9606-17. doi: 10.1021/bi900510f.
8
Slow thrombin is zymogen-like.慢凝血酶类似酶原。
J Thromb Haemost. 2009 Jul;7 Suppl 1(S1STATE):159-64. doi: 10.1111/j.1538-7836.2009.03365.x.
9
Von Willebrand factor-binding protein is a hysteretic conformational activator of prothrombin.血管性血友病因子结合蛋白是凝血酶原的一种滞后构象激活剂。
Proc Natl Acad Sci U S A. 2009 May 12;106(19):7786-91. doi: 10.1073/pnas.0811750106. Epub 2009 Apr 28.
10
Alternative proteolytic processing of hepatocyte growth factor during wound repair.伤口修复过程中肝细胞生长因子的替代性蛋白水解加工
Am J Pathol. 2009 Jun;174(6):2116-28. doi: 10.2353/ajpath.2009.080597. Epub 2009 Apr 23.